Open Access

Predominance of synovial sensory nerve fibers in arthrofibrosis following total knee arthroplasty compared to osteoarthritis of the knee

  • Franz Xaver Koeck1Email author,
  • Miriam Schmitt2,
  • Clemens Baier3,
  • Hubert Stangl2,
  • Johannes Beckmann4,
  • Joachim Grifka3 and
  • Rainer H. Straub2
Contributed equally
Journal of Orthopaedic Surgery and Research201611:25

https://doi.org/10.1186/s13018-016-0359-0

Received: 9 January 2016

Accepted: 11 February 2016

Published: 17 February 2016

Abstract

Background

So far, there exists no golden standard for the treatment of arthrofibrosis (AF) following total knee arthroplasty (TKA). Although pain is a hallmark of AF, nociceptive nerve fibers have never been investigated in affected joint tissue.

Methods

A total of 24 patients with osteoarthritis (OA) of the knee (n = 12) and post-TKA AF of the knee (n = 12) were included. Along evaluation of typical clinical signs and symptoms by using the Knee Society Clinical Rating System (KSS), the Knee Injury and Osteoarthritis Outcome Score (KOOS), and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC index), the innervation of joint tissue was studied by semiquantitative immunofluorescence of nerve fibers.

Results

Patients with AF compared to OA had a lower KSS and lower KOOS. In all compartments (anterior, medial, and lateral recesses), the density of synovial sympathetic nerve fibers was significantly higher in OA compared to AF, which was also true for the density of sensory nerve fibers in the medial and lateral recesses. In synovial tissue of the anterior recess of patients with AF compared to OA, the density of nociceptive sensory nerve fibers was significantly higher relative to sympathetic nerve fibers. This was similarly observed in the neighboring infrapatellar fat pad of the knee.

Conclusions

Similar as in many painful musculoskeletal diseases, this study indicates that patients with arthrofibrosis of the knee after TKA demonstrate a preponderance of profibrotic sensory nerve fibers over antifibrotic sympathetic nerve fibers. This could serve as a starting point for AF therapy with specific antifibrotic pain medication or regional anesthetic techniques.

Keywords

Arthrofibrosis Knee Osteoarthritis Arthroplasty Nerve fibers

Background

Arthroplasty is a safe and satisfactory procedure in the therapy of degenerative knee pathologies. Most people experience great benefit with regard to mobility and quality of life even in long-term follow-up after total knee arthroplasty (TKA) [1, 2]. Nevertheless, reduced motion and stiffness can be a frustrating complication for both, the patient and the surgeon. This is often linked to persistent pain and marked functional problems. Since the beginning of the 1990s, stiffness due to an exaggerated scar formation as observed after anterior cruciate ligament reconstruction was called arthrofibrosis of the knee [3]. In the context of TKA, prevalence of arthrofibrosis (AF) ranges between 1.5 and 4.5 % of all TKA operations [4, 5]. Although no consensus as to the treatment of AF exists, four major procedures are used in patients with AF: (1) closed manipulation under anesthesia [6], (2) arthroscopic debridement and lysis [7], (3) open debridement and lysis of scar tissue, and (4) revision arthroplasty [8, 9]. However, it is well known that each kind of manipulation including revision surgery means additional mechanical stress, which is afflicted with a high risk of recurrence of fibrosis [6]. Also, increased psychological distress is supposed to be a risk factor for postoperative stiffness in TKA [10]. While these problems are recognized, the etiology of postoperative AF is not well understood.

There are several important starting points in the etiology of AF. Activation of the fibroblast and myofibroblast is an important aspect with increased production of collagen type VI [11], alpha-smooth muscle protein [12], β-catenin [13], reactive oxygen and nitrogen species (also in macrophages and neutrophils) [14], and bone morphogenic protein type II [15]. The proinflammatory cytokine interleukin (IL)-1β might also play a role since injection of anakinra, the IL-1 receptor antagonist, was effective in an open study in AF patients [16]. Contiguous to fibroblasts, also profibrotic mast cells and T lymphocytes are involved in the scaring process in AF [17, 18]. Under experimental conditions in animals, transforming growth factor beta and vascular endothelial growth factor were found to be associated with fibrosis [19, 20]. In addition, sonographic studies in humans demonstrated increased neovascularization in the synovial tissue and infrapatellar fat pad (Hoffa) [4]. All these factors relevant for a profibrotic process demonstrate a continuous smoldering low-grade inflammation characterized as a new type of synovialitis [13].

Notwithstanding the enormous progress made, it remains unclear why AF is painful and why this may be linked to scar formation. Articular pain is signaled to the central nervous system via peripheral sensory nociceptive nerve fibers, which are equipped with the major neurotransmitter substance P [21].

In patients with TKA-derived AF of the knee (controls: OA patients), this study was initiated to investigate, in parallel, the density of peripheral sensory nociceptive nerve fibers and the density of peripheral sympathetic nerve fibers in synovial tissue of the knee joint. Patients were characterized by classical instruments such as the Knee Society Clinical Rating System (KSS), the Knee Injury and Osteoarthritis Outcome Score (KOOS), and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC index) [2224]. The proliferative process in articular tissue was estimated by cellular density, which was a perfect marker of synovialitis related to AF [13].

Methods

A total of 24 patients with OA of the knee (n = 12) and AF after TKA (n = 12) were included. The characteristics of the patients are given in Table 1. The two groups were not different in age, sex, and systemic inflammation measured by the erythrocyte sedimentation rate or C-reactive protein (Table 1).
Table 1

Characteristics of patients under study

 

Osteoarthritis of the knee

Arthrofibrosis of the knee

Number of patients

12

12

Age, year

69.2 ± 2.4 [59–86]

66.4 ± 2.4 [55–77]

Gender, men/women

3/9 (25/75)

4/8 (33/67)

Indication for operation

12, primary total knee arthroplasty

12, revision after total knee arthroplasty

Affected side, right/left

6/6

7/5

C-reactive protein, mg/l

3.2 ± 0.6 [0.4–7.2]

8.0 ± 2.9 [0.7–36.6]

Erythrocyte sedimentation rate, mm 1st hour

8 ± 2 [2–19]

21 ± 8 [2–76]

Data are given as means ± SEM, percentages in parentheses, and ranges in brackets

The patients with knee OA underwent primary total knee joint replacement surgery, and the patients with AF underwent open revision with debridement and lysis of scar tissue. All patients were informed about the purpose of the study and gave written consent. The study was approved by the Ethical Committee of the University of Regensburg (No. 11-101-0220).

Severity of joint disease was characterized by the KSS, the KOOS, and the WOMAC index according to standard questionnaires [2224]. The KSS is a simple but objective scoring system to rate the knee and patient’s functional abilities such as walking and stair climbing before and after TKA [2224]. The KOOS is developed as an extension of the WOMAC index with the purpose of evaluating short-term and long-term symptoms and function in subjects with knee injury and osteoarthritis. It holds five subscales: pain other symptoms, function in daily living, in sport, and recreation, and knee-related quality of life [2224]. The WOMAC osteoarthritis index assesses pain, stiffness, and physical function in patients with hip and/or knee OA. It consists of 24 items divided into three subscales (pain, stiffness, and physical function) [2224].

Although knowing that OA and AF might not differ much in expression of joint complaints and signs of inflammation, we studied these two independent patients groups in order to present comparative groups.

The preparation of the tissue for histology was as described [25]. Fat tissue of the infrapatellar fat pad and synovial tissue of the medial, lateral, and anterior recesses of the knee joint were used for histology. Samples intended for the determination of cell density and detection of nerve fibers were fixed, depending on sample size, for 18 to 48 h in phosphate-buffered saline (PBS) containing 3.7 % formaldehyde and then incubated in PBS with 20 % sucrose for 18 to 48 h. Thereafter, the tissue was embedded in Tissue Tek (Tissue Tek, Sakura Finetek, Zoeterwoude, The Netherlands) and quick-frozen floating on liquid nitrogen.

Histological evaluation has been described in an earlier study [26]. Briefly, the frozen tissue samples were cut into 8–9-μm-thick sections, and cell density was evaluated using DAPI (4′,6-diamidino-2-phenylindol) staining. Cellular density in the tissue was determined by counting stained cells in 17 randomly selected high-power fields (400×) and expressed per square millimeter.

The determination of synovial innervation has been described previously [25]. We used a primary antibody against tyrosine hydroxylase (TH+, the key enzyme for NE production in sympathetic nerve endings, cat. no. AB152, Chemicon, Temecula, CA, USA) and against substance P (SP+, the key neurotransmitter of SP+ sensory nerve fibers, cat. no. AB1977, Chemicon). We used an Alexa 546-conjugated secondary antibody (cat. no. A-11010, goat against rabbit IgG, Molecular Probes, Leiden, The Netherlands) to achieve immunofluorescent staining of sympathetic and sensory substance P-positive nerve fibers (Fig. 1).
Fig. 1

Representative immunohistochemistry of substance P (SP)-positive sensory nerve fibers and sympathetic tyrosine hydroxylase (TH)-positive nerve fibers. a, b SP-positive sensory nerve fibers embedded in extracellular matrix (a) and following a larger synovial tissue artery (b; blue fluorescence staining = DAPI, 4′,6-diamidino-2-phenylindol). c, d TH-positive sympathetic nerve fibers embedded in extracellular matrix (green intrinsic fluorescence demonstrating fibrillar structures). Micrographs were taken at ×400 magnification

The numbers of TH+ sympathetic and SP+ sensory nerve fibers per square millimeter were determined by averaging the number of stained nerve fibers (typical bead chain structure with at least four separated vesicles along the axon, minimum length 50 μm, determined by a micrometer eyepiece) in 17 randomly selected high-power fields of view (400×). We controlled the positive nerve fiber staining by incubating the tissue with polyclonal control antibodies which always yielded a negative result (no red fluorescent staining).

All data are given as mean ± SEM. Box plots give the 10th, 75th, 50th (median), 25th, and 10th percentile. Group medians were compared by the non-parametric Mann-Whitney test (SPSS/PC, Advanced Statistics, V18.0, SPSS Inc., Chicago). p < 0.05 was the significance level. Due to the explorative nature of the study, we did not adjust for multiple use of the same data.

Results

The patients with AF demonstrated a significantly higher Knee Society knee score than the OA patients (Table 2). In addition, the AF compared to the OA patients demonstrated a significantly reduced knee-related quality of life as estimated using the KOOS questionnaire (Table 2). In a form of a trend, pain appeared more severe in the patients with AF compared to OA, however not significantly (Table 2).
Table 2

Clinical parameters of patients under study

 

Osteoarthritis of the knee

Arthrofibrosis of the knee

Knee Society knee score, points

43 ± 5

33 ± 3*

Knee Society function score, points

52 ± 5

47 ± 6

KOOS pain, points

38 ± 4

28 ± 4**

KOOS other symptoms, points

43 ± 4

33 ± 4

KOOS function in daily living, points

36 ± 4

29 ± 5

KOOS function in sport and recreation, points

7.5 ± 2.8

2.5 ± 1.1

KOOS knee-related quality of life, points

23 ± 3

15 ± 4*

WOMAC pain, points

11 ± 1

13 ± 1

WOMAC stiffness, points

5.0 ± 0.4

5.7 ± 0.4

WOMAC function, points

42 ± 2

47 ± 3

WOMAC total, points

58 ± 4

65 ± 4

Thigh circumference 20 cm above knee, cm

55 ± 3

52 ± 2

Thigh circumference 10 cm above knee, cm

48 ± 3

45 ± 1

Thigh circumference at knee joint, cm

43 ± 1

43 ± 1

Data are given as means ± SEM, percentages in parentheses, and ranges in brackets

KOOS Knee Injury and Osteoarthritis Outcome Score

*p < 0.05; **p = 0.072 for comparison of the two groups

In all recesses (anterior, medial, lateral), the synovial density of sympathetic nerve fibers was significantly higher in the OA compared to the AF patients (Fig. 2a). Similarly, in the medial and lateral recesses, the synovial density of substance P-positive sensory nerve fibers was significantly higher in OA compared to AF (Fig. 2b). This indicates that the scaring tissue in AF contains less sympathetic and sensory nerve fibers compared to the OA control group (Fig. 2).
Fig. 2

Density of sympathetic tyrosine hydroxylase-positive (TH+) and sensory substance P-positive (SP+) nerve fibers in synovial tissue of three different recesses of the knee in patients with osteoarthritis (OA) and arthrofibrosis (AF). a Density of sympathetic nerve fibers. b Density of sensory nerve fibers. A circular symbol is the mean value of 17 investigated high-power fields of one patient. Box plots give the 10th, 75th, 50th (median), 25th, and 10th percentiles. n.s. not significant

In order to study a preponderance of a nerve fiber type over the other, ratios were generated in every patient with the density of substance P-positive nerve fibers in the nominator and the density of sympathetic nerve fibers in the denominator [25, 27]. In the anterior recess of the knee, this particular ratio was higher in the patients with AF compared to the patients with OA (Fig. 3). Although a similar trend existed for the medial and lateral recesses of the knee, this did not reach a significant level (Fig. 3).
Fig. 3

Ratio of density of substance P-positive sensory nerve fibers (SP+) divided by density of tyrosine hydroxylase-positive sympathetic nerve fibers (TH+) in the three recesses of the knee joint. A circular symbol is the ratio of one individual patient. Box plots are explained in the legend of Fig. 2. AF arthrofibrosis, n.s. not significant, OA osteoarthritis

Since the phenomenon of sensory hyperinnervation in relation to sympathetic innervation was mainly detected in the anterior recess of the knee, additional investigation of the neighboring infrapatellar fat pad (Hoffa) was stimulated. While the density of sympathetic nerve fibers was higher in OA compared to AF (Fig. 4, left panel), the density of substance P-positive sensory nerve fibers was not different between groups (Fig. 4, middle panel). A relative preponderance of sensory over sympathetic nerve fibers in AF compared to OA could be detected when generating the density ratio of substance P-positive divided by sympathetic nerve fibers (Fig. 4, left panel).
Fig. 4

Density of sympathetic tyrosine hydroxylase-positive (TH+) and sensory substance P-positive (SP+) nerve fibers in infrapatellar fat pad in patients with osteoarthritis (OA) and arthrofibrosis (AF). Box plots are explained in the legend of Fig. 2. n.s. not significant

Discussion

To our best knowledge, this is the first study to investigate sensory and sympathetic nerve fiber densities in articular tissue in patients with AF of the knee. The density of sympathetic and sensory nerve fibers was generally higher in OA compared to AF, which probably demonstrates a higher degree of fibrotic scar formation in AF than OA tissue. In addition, in AF compared to OA, in the anterior recess and in the infrapatellar fat pad, the density of sensory nerve fibers was higher in relation to the density of sympathetic nerve fibers. This indicates a preponderance of profibrotic sensory nerve fibers over antifibrotic sympathetic nerve fibers. This phenomenon seems to be located solely in anterior compartments.

Sensory hyperinnervation in relation to sympathetic innervation as a consequence of chronic mechanical or inflammatory stimulation of the tissue has been observed in several diseases: (1) osteonecrosis of the femoral head [28], (2) chronic pruritus and prurigo nodularis [29], (3) Charcot foot [30], (4) Dupuytren’s contracture nodules [31], (5) painful Achilles tendinosis [32], and (6) rheumatoid arthritis [25]. Hyperinnervation can be a consequence of increased production of nerve growth factor which is often observed during inflammation [33]. In AF, early postoperative pain is often related to the ongoing arthrofibrotic process. Thus, we hypothesize that continuous stimulation of pain fibers induces inflammation, and inflammation itself stimulates relative sensory hyperinnervation leading to perpetuation of the process. This might be a possibility for a therapeutical approach of AF in order to perforate this vicious circle. So far, therapeutical strategies focus on closed or open manipulation and mobilization techniques under anesthesia and intense physiotherapy with appropriate pain medication. However, studies report of little success and an increased risk of another revision [34].

Substance P has a strong effect on fibroblast activation and extracellular matrix production leading to increased scar formation [35]. In addition, substance P is a proinflammatory neuropeptide that can aggravate a continuous inflammatory process: substance P stimulates IL-1 and tumor necrosis factor (TNF) from various cell types [36]. We recently demonstrated sprouting of substance P-positive nerve fibers in diseases with exaggerated fibrogenesis such as rheumatoid arthritis, Achilles tendinosis, and Dupuytren’s contracture [25, 31, 32]. Sensory hyperinnervation and substance P might be important factors for aggravation and continuation of AF.

In contrast to substance P, neurotransmitters of the sympathetic nerve endings can have anti-inflammatory effects at high neurotransmitter concentrations: norepinephrine binds preferentially α-adrenoceptors (at high physiological concentrations also to β-adrenoceptors). Adenosine preferentially binds adenosine 1 (A1) receptors (at high physiological concentrations also to adenosine 2 (A2) receptors) [25, 31, 32]. Ligation of β-adrenoceptors or A2 adenosine receptors increase intracellular cyclic adenosine monophosphate (cAMP) levels and ligation of α2-adrenoceptors or A1 adenosine receptors decrease intracellular cAMP levels [25, 31, 32]. Generally, an elevated sympathetic tone due to increased firing rates at sympathetic nerves results in increased levels of norepinephrine and adenosine in the vicinity of the nerve terminal. This leads to an increase of intracellular cAMP in multiple peripheral target cells. Elevation of cAMP by these mechanisms has been repeatedly demonstrated to induce many anti-inflammatory effects on target immune mechanisms such as secretion of TNF or interferon-γ [25, 31, 32]. Thus, the presence of sympathetic nerves at a high fiber density would yield a high enough anti-inflammatory concentration of norepinephrine and adenosine [25, 31, 32]. In addition, sympathetic nerve terminals bear vesicles with endogenous opioids which are able to inhibit release of the proinflammatory substance P from sensory nociceptive nerve fibers [37]. In a highly inflammatory disease such as rheumatoid arthritis, the preponderance of substance P-positive nerve fibers over sympathetic nerve fibers is approximately 8:1, whereas in healthy tissue, the density of sensory versus sympathetic nerve fibers is balanced at 1:1 [25]. Taken together, the presence of sympathetic nerve fibers leading to high concentrations of sympathetic neurotransmitters can inhibit proinflammatory effects of substance P, which might be also relevant in AF. However, the parallel investigation of sensory and sympathetic nerve fibers has never been reported in this TKA complication.

In the scenario of AF, substance P is not a simple bystander but a strong profibrotic factor leading to fibroblast activation and extracellular matrix production [35, 38]. Substance P is a proinflammatory neuropeptide that aggravates a continuous inflammatory process [36, 39]. In the absence of anti-inflammatory catecholaminergic influences, substance P predominance might trigger a vicious circle leading to exaggerated scar formation. It is interesting that this phenomenon only appears in the anterior compartments of the anterior recess and the infrapatellar fat pad. Since the anterior compartments are more prone to mechanical stress, this region is particularly affected.

We are unable to describe the sequence of events and causality in humans because removal of tissue cannot be done in a serial way and manipulations of substance P release cannot be tested. Future studies might address this important aspect in animal models of AF as these models exist in rats and rabbits [19, 20]. In these models, one might block the activity of substance P by specific receptor antagonists, or one might use tachykinin 1-deficient (Tac1−/−) mice (no SP) in order to specify the role of substance P. In the rat model, Watson et al. described that transforming growth factor beta is an outstandingly important stimulus of AF, which nicely fits to the fact that substance P is a perfect stimulator of this cytokine [40]. In addition, transforming growth factor beta stimulates the substance P receptor in a way that the substance P signaling pathway is more active over a longer period of time [41]. Thus, the pain pathway and the fibrosis pathway are tightly coupled. This is also true for the presence of mast cells because substance P sensory nerve fibers are closely linked to mast cells, [34] and mast cells are predominant in fibrotic tissue not tested in the present study [42]. These aspects could serve as a foundation for the development of new drugs interrupting the abovementioned pathways. A limitation of this study might be the relatively small numbers of patients and controls. We also are aware that the ideal control group would be patients without OA which is also known as an inflammatory disease [30, 37]. But as described, this was not feasible due to ethical reasons and the fact that the needed volume of synovial tissue could not be acquired arthroscopically.

Conclusions

This study indicates that AF patients have hyperinnervation with sensory nerve fibers relative to sympathetic nerve fibers in the anterior compartments of the knee after total knee arthroplasty. Substance P of sensory nerve fibers is probably a critical element in this process because this neuropeptide has profibrotic capacities and stimulates transforming growth factor beta. Future studies in animal models of AF are needed to investigate the role of manipulation of the sensory nervous system.

Declarations

Acknowledgements

This study was partly supported by a grant from the Deutsche Forschungsgemeinschaft (STR 511/26-1).

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
MedArtes - Private Orthopaedic Clinic
(2)
Laboratory of Experimental Rheumatology and Neuroendocrine Immunology, Department of Internal Medicine I, University Hospital Regensburg
(3)
Department of Orthopedic Surgery, University of Regensburg
(4)
Sportklinik Stuttgart

References

  1. Ritter MA, Berend ME, Meding JB, et al. 2001. Long-term followup of anatomic graduated components posterior cruciate-retaining total knee replacement. Clin Orthop Relat Res. (388): 51–57Google Scholar
  2. Sextro GS, Berry DJ, Rand JA. 2001. Total knee arthroplasty using cruciate-retaining kinematic condylar prosthesis. Clin Orthop Relat Res (388): 33–40Google Scholar
  3. Mohtadi NG, Webster-Bogaert S, Fowler PJ. Limitation of motion following anterior cruciate ligament reconstruction. A case–control study. Am J Sports Med. 1991;19(6):620–4. discussion 624–5.View ArticlePubMedGoogle Scholar
  4. Boldt JG, Munzinger UK, Zanetti M, et al. Arthrofibrosis associated with total knee arthroplasty: gray-scale and power Doppler sonographic findings. AJR Am J Roentgenol. 2004;182(2):337–40. doi:10.2214/ajr.182.2.1820337.View ArticlePubMedGoogle Scholar
  5. Ipach I, Mittag F, Lahrmann J, et al. Arthrofibrosis after TKA—influence factors on the absolute flexion and gain in flexion after manipulation under anaesthesia. BMC Musculoskelet Disord. 2011;12:184. doi:10.1186/1471-2474-12-184.PubMed CentralView ArticlePubMedGoogle Scholar
  6. Werner BC, Carr JB, Wiggins JC, et al. Manipulation under anesthesia after total knee arthroplasty is associated with an increased incidence of subsequent revision surgery. J Arthroplasty. 2015. doi:10.1016/j.arth.2015.01.061.Google Scholar
  7. Tjoumakaris FP, Tucker BC, Post Z, et al. Arthroscopic lysis of adhesions for the stiff total knee: results after failed manipulation. Orthopedics. 2014;37(5):e482–7. doi:10.3928/01477447-20140430-60.View ArticlePubMedGoogle Scholar
  8. Ghani H, Maffulli N, Khanduja V. Management of stiffness following total knee arthroplasty: a systematic review. Knee. 2012;19(6):751–9. doi:10.1016/j.knee.2012.02.010.View ArticlePubMedGoogle Scholar
  9. Sharkey PF, Lichstein PM, Shen C, et al. Why are total knee arthroplasties failing today—has anything changed after 10 years? J Arthroplasty. 2014;29(9):1774–8. doi:10.1016/j.arth.2013.07.024.View ArticlePubMedGoogle Scholar
  10. Lavernia CJ, Villa JM, Iacobelli DA. What is the role of mental health in primary total knee arthroplasty? Clin Orthop Relat Res. 2015;473(1):159–63. doi:10.1007/s11999-014-3769-5.PubMed CentralView ArticlePubMedGoogle Scholar
  11. Zeichen J, van Griensven M, Albers I, et al. Immunohistochemical localization of collagen VI in arthrofibrosis. Arch Orthop Trauma Surg. 1999;119(5–6):315–8.View ArticlePubMedGoogle Scholar
  12. Unterhauser FN, Bosch U, Zeichen J, et al. Alpha-smooth muscle actin containing contractile fibroblastic cells in human knee arthrofibrosis tissue. Winner of the AGA-DonJoy Award 2003. Arch Orthop Trauma Surg. 2004;124(9):585–91. doi:10.1007/s00402-004-0742-x.View ArticlePubMedGoogle Scholar
  13. Krenn V, Ruppert M, Knöß P, et al. Synovialitis vom arthrofibrotischen Typ: Kriterien eines neuen Synovialitis-Typus für die Diagnose der Arthrofibrose (Synovialitis of the arthrofibrotic type: criteria of a new synovialitis type for the diagnosis of arthrofibrosis). Z Rheumatol. 2013;72(3):270–8. doi:10.1007/s00393-012-1076-7.View ArticlePubMedGoogle Scholar
  14. Freeman TA, Parvizi J, Della Valle CJ, et al. Reactive oxygen and nitrogen species induce protein and DNA modifications driving arthrofibrosis following total knee arthroplasty. Fibrogenesis Tissue Repair. 2009;2(1):5. doi:10.1186/1755-1536-2-5.PubMed CentralView ArticlePubMedGoogle Scholar
  15. Pfitzner T, Geissler S, Duda G, et al. Increased BMP expression in arthrofibrosis after TKA. Knee Surg Sports Traumatol Arthrosc. 2012;20(9):1803–8. doi:10.1007/s00167-011-1774-8.View ArticlePubMedGoogle Scholar
  16. Brown CA, Toth AP, Magnussen B. Clinical benefits of intra-articular anakinra for arthrofibrosis. Orthopedics. 2010;33(12):877. doi:10.3928/01477447-20101021-09.PubMedGoogle Scholar
  17. Bosch U, Zeichen J, Skutek M, et al. Arthrofibrosis is the result of a T cell mediated immune response. Knee Surg Sports Traumatol Arthrosc. 2001;9(5):282–9. doi:10.1007/s001670100218.View ArticlePubMedGoogle Scholar
  18. Freeman TA, Parvizi J, Dela Valle CJ, et al. Mast cells and hypoxia drive tissue metaplasia and heterotopic ossification in idiopathic arthrofibrosis after total knee arthroplasty. Fibrogenesis Tissue Repair. 2010;3:17. doi:10.1186/1755-1536-3-17.PubMed CentralView ArticlePubMedGoogle Scholar
  19. Emami MJ, Jaberi FM, Azarpira N, et al. Prevention of arthrofibrosis by monoclonal antibody against vascular endothelial growth factor: a novel use of bevacizumab in rabbits. Orthop Traumatol Surg Res. 2012;98(7):759–64. doi:10.1016/j.otsr.2012.05.020.View ArticlePubMedGoogle Scholar
  20. Watson RS, Gouze E, Levings PP, et al. Gene delivery of TGF-β1 induces arthrofibrosis and chondrometaplasia of synovium in vivo. Lab Invest. 2010;90(11):1615–27. doi:10.1038/labinvest.2010.145.PubMed CentralView ArticlePubMedGoogle Scholar
  21. Basbaum AI, Bautista DM, Scherrer G, et al. Cellular and molecular mechanisms of pain. Cell. 2009;139(2):267–84. doi:10.1016/j.cell.2009.09.028.PubMed CentralView ArticlePubMedGoogle Scholar
  22. Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988;15(12):1833–40.PubMedGoogle Scholar
  23. Insall JN, Dorr LD, Scott RD, et al. 1989. Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res. (248): 13–14Google Scholar
  24. Roos EM, Roos HP, Lohmander LS, et al. Knee Injury and Osteoarthritis Outcome Score (KOOS)—development of a self-administered outcome measure. J Orthop Sports Phys Ther. 1998;28(2):88–96. doi:10.2519/jospt.1998.28.2.88.View ArticlePubMedGoogle Scholar
  25. Weidler C, Holzer C, Harbuz M, et al. Low density of sympathetic nerve fibres and increased density of brain derived neurotrophic factor positive cells in RA synovium. Ann Rheum Dis. 2005;64(1):13–20. doi:10.1136/ard.2003.016154.PubMed CentralView ArticlePubMedGoogle Scholar
  26. Miller LE, Grifka J, Schölmerich J, et al. Norepinephrine from synovial tyrosine hydroxylase positive cells is a strong indicator of synovial inflammation in rheumatoid arthritis. J Rheumatol. 2002;29(3):427–35.PubMedGoogle Scholar
  27. Lehner B, Koeck FX, Capellino S, et al. Preponderance of sensory versus sympathetic nerve fibers and increased cellularity in the infrapatellar fat pad in anterior knee pain patients after primary arthroplasty. J Orthop Res. 2008;26(3):342–50. doi:10.1002/jor.20498.View ArticlePubMedGoogle Scholar
  28. Beckmann J, Knödl M, Bauser E, et al. Loss of sympathetic nerve fibers in vital intertrochanteric bone cylinders lateral to osteonecrosis of the femoral head. Joint Bone Spine. 2013;80(2):188–94. doi:10.1016/j.jbspin.2012.03.003.View ArticlePubMedGoogle Scholar
  29. Haas S, Capellino S, Phan NQ, et al. Low density of sympathetic nerve fibers relative to substance P-positive nerve fibers in lesional skin of chronic pruritus and prurigo nodularis. J Dermatol Sci. 2010;58(3):193–7. doi:10.1016/j.jdermsci.2010.03.020.View ArticlePubMedGoogle Scholar
  30. Koeck F, Bobrik V, Fassold A, et al. Marked loss of sympathetic nerve fibers in chronic Charcot foot of diabetic origin compared to ankle joint osteoarthritis. J Orthop Res. 2009;27(6):736–41. doi:10.1002/jor.20807.View ArticlePubMedGoogle Scholar
  31. Schubert TEO, Weidler C, Lerch K, et al. Achilles tendinosis is associated with sprouting of substance P positive nerve fibres. Ann Rheum Dis. 2005;64(7):1083–6. doi:10.1136/ard.2004.029876.PubMed CentralView ArticlePubMedGoogle Scholar
  32. Schubert TEO, Weidler C, Borisch N, et al. Dupuytren’s contracture is associated with sprouting of substance P positive nerve fibres and infiltration by mast cells. Ann Rheum Dis. 2006;65(3):414–5. doi:10.1136/ard.2005.044016.PubMed CentralView ArticlePubMedGoogle Scholar
  33. Aloe L, Tuveri MA, Carcassi U, et al. Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis Rheum. 1992;35(3):351–5.View ArticlePubMedGoogle Scholar
  34. Stead RH, Dixon MF, Bramwell NH, et al. Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology. 1989;97(3):575–85.PubMedGoogle Scholar
  35. Burssens P, Steyaert A, Forsyth R, et al. Exogenously administered substance P and neutral endopeptidase inhibitors stimulate fibroblast proliferation, angiogenesis and collagen organization during Achilles tendon healing. Foot Ankle Int. 2005;26(10):832–9.PubMedGoogle Scholar
  36. Lotz M, Vaughan JH, Carson DA. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science. 1988;241(4870):1218–21.View ArticlePubMedGoogle Scholar
  37. Konttinen YT, Kemppinen P, Segerberg M, et al. Peripheral and spinal neural mechanisms in arthritis, with particular reference to treatment of inflammation and pain. Arthritis Rheum. 1994;37(7):965–82.View ArticlePubMedGoogle Scholar
  38. Katayama I, Nishioka K. Substance P augments fibrogenic cytokine-induced fibroblast proliferation: possible involvement of neuropeptide in tissue fibrosis. J Dermatol Sci. 1997;15(3):201–6.View ArticlePubMedGoogle Scholar
  39. Lieb K, Fiebich BL, Berger M, et al. The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. J Immunol. 1997;159(10):4952–8.PubMedGoogle Scholar
  40. Lai X, Wang Z, Zhu J, et al. Effect of substance P on gene expression of transforming growth factor beta-1 and its receptors in rat’s fibroblasts. Chin J Traumatol. 2003;6(6):350–4.PubMedGoogle Scholar
  41. Beinborn M, Blum A, Hang L, et al. TGF-beta regulates T-cell neurokinin-1 receptor internalization and function. Proc Natl Acad Sci USA. 2010;107(9):4293–8. doi:10.1073/pnas.0905877107.PubMed CentralView ArticlePubMedGoogle Scholar
  42. Monument MJ, Hart DA, Befus AD, et al. The mast cell stabilizer ketotifen reduces joint capsule fibrosis in a rabbit model of post-traumatic joint contractures. Inflamm Res. 2012;61(4):285–92. doi:10.1007/s00011-011-0409-3.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Koeck et al. 2016

Advertisement